SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 97,418.51 |
| Enterprise Value ($M) | 83,160.11 |
| Book Value ($M) | 25,973.10 |
| Book Value / Share | 241.70 |
| Price / Book | 3.75 |
| NCAV ($M) | 17,382.00 |
| NCAV / Share | 161.75 |
| Price / NCAV | 5.60 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.14 |
| Return on Assets (ROA) | 0.13 |
| Return on Equity (ROE) | 0.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.74 |
| Current Ratio | 6.41 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 24,489.10 |
| Assets | 33,080.20 |
| Liabilities | 7,107.10 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 13,117.20 |
| Operating Income | 4,358.60 |
| Net Income | 3,953.60 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 4,594.00 |
| Cash from Investing | -3,185.10 |
| Cash from Financing | -1,790.10 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 8.25 | 1.33 | |
| 13G/A | Fmr Llc | 9.63 | -7.03 | |
| 13G/A | Capital World Investors | 4.80 | -17.75 | |
| 13G/A | Jpmorgan Chase & Co | 6.70 | 18.33 | |
| 13G/A | BlackRock Inc. | 8.10 | -5.86 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 74,680 | 453,224 | 16.48 | |
| 59,041 | 285,129 | 20.71 | |
| 51,050 | 228,997 | 22.29 | |
| 40,671 | 147,635 | 27.55 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| QURE – uniQure N.V. | RARE – Ultragenyx Pharmaceutical Inc. |
| RDUS – Radius Recycling, Inc. | REPL – Replimune Group, Inc. |
| RGEN – Repligen Corporation |
Financial data and stock pages provided by
Fintel.io